December 20, 2012 “Intelligence: Late Breaking Lab News”

Consolidation of in vitro diagnostics (IVD) manufacturers continues to help industry leaders become ever bigger. When Hologic, Inc., of Bedford, Massachusetts, reported its third quarter earnings last month, it reported that diagnostics is now the largest business segment at the $2.6 billion company, following its acquisition of Gen-Probe, Inc., last August. For third quarter, total revenue at Hologic was $589 million, of which diagnostics comprised

$253.5 million, or 43% of Hologic’s total revenue. The company noted that it had seen strong growth in its ThinPrep and molecular diagnostics product lines.


In just a few weeks, Abbott Laboratories, Inc., will split into two companies. The goal is to separate the pharmaceuticals business from the other product lines at Abbott. There is likely to be little visible change for the clinical laboratory customers. That is because diagnostics, devices, and nutritional products will continue to be sold in the company that will retain the name Abbott Laboratories. The pharmaceuticals and medical products business will move to a new company called AbbVie and will use the stock symbol of ABBV.

MORE ON: Abbott

Rick Gonzalez, a long-time Abbott executive, will be CEO of AbbVie. Miles White, current CEO of Abbott Laboratories, will remain CEO of that company after January 1, 2013. Abbott Laboratories is one of the top five global in vitro diagnostics manufacturers when measured by revenue.


  • ClearPath Diagnostics of Syracuse, New York, announced the appointment of Jack Finn as its new CEO. Finn was formerly President and CEO of Centrex Clinical Laboratories, where he served for 25 years.
  • David L. Smalley, Ph.D., is the new President of the Mid-South Division of American Esoteric Laboratories (AEL), headquartered in Memphis, Tennessee. AEL is itself a division of Sonic Healthcare USA. Smalley had previously been Director of the Tennessee State Public Health Laboratory and recently retired as a Brigadier General from a 30-year career in the U.S. Army Reserves.


Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

…the second pathologist in a decade to become a Nobel Laureate. It is Robert J. Lefkowitz, M.D., of Duke University Medical Center. This fall he was awarded a share of the 2012 Nobel Prize in Chemistry.

You can get the free DARK Daily e-briefings by signing up at


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.